› 2ptz

X-ray diffraction
1.65Å resolution

Crystal Structure of the T. brucei enolase complexed with phosphonoacetohydroxamate (PAH), His156-out conformation

Released:
DOI: 10.2210/pdb2ptz/pdb
PDB 2ptz coloured by chain and viewed from the front.
PDB 2ptz coloured by chain and viewed from the side.
PDB 2ptz coloured by chain and viewed from the top.
Source organism: Trypanosoma brucei
Primary publication:
Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics.
de A S Navarro MV, Gomes Dias SM, Mello LV, da Silva Giotto MT, Gavalda S, Blonski C, Garratt RC, Rigden DJ
FEBS J. 274 5077-89 (2007)
PMID: 17822439

Function and Biology Details

Reaction catalysed: 
2-phospho-D-glycerate = phosphoenolpyruvate + H(2)O
Biochemical function:
Biological process:
Cellular component:
Sequence domains:
Structure domains:

Structure analysis Details

Assembly composition:
homo dimer (preferred)
Entry contents:
1 distinct polypeptide molecule
Macromolecule:
phosphopyruvate hydratase Chain: A
Molecule details ›
Chain: A
Length: 432 amino acids
Theoretical weight: 46.9 KDa
Source organism: Trypanosoma brucei
Expression system: Escherichia coli
UniProt:
  • Canonical: Q38BV6 (Residues: 1-429; Coverage: 100%)
Gene name: Tb10.70.4740
Sequence domains:
Structure domains:

Ligands and Environments

3 bound ligands:
Ligand ZN 3 x ZN
Ligand PAH 1 x PAH
Ligand EDO 1 x EDO
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: LNLS BEAMLINE D03B-MX1
Spacegroup: C2221
Unit cell:
a: 73.858Å b: 109.279Å c: 107.946Å
α: 90° β: 90° γ: 90°
R-values:
R R work R free
0.167 0.165 0.203
Expression system: Escherichia coli

Quick links

Citations

3 review citations

The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
Ogungbe et al. (2016)
2 more

3 mentions without citation

Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target.
Avilán et al. (2011)
2 more